EGF and breast carcinoma: To understand whether there are distinct genomic responses in relation to the biphasic signaling response, we conducted a comprehensive analysis of the whole genomic response for both HRG and EGF ligand activation on the ErbB receptor of MCF-7 breast cancer cells by grouping genes based on time-dependent changes in expression.